COVID-19: Sinovac Starts Vaccine Clinical Trial On Children In South Africa
JOHANNESBURG. — Chinese pharmaceutical company Sinovac Biotech last Friday launched the Phase III clinical trial of its Covid-19 vaccine on a group of children and teenagers between six months and 17 years old in South Africa.
